Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of Complement
Open Access
- 1 April 2009
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 284 (16), 10473-10479
- https://doi.org/10.1074/jbc.m809106200
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Structural insight into distinct mechanisms of protease inhibition by antibodiesProceedings of the National Academy of Sciences of the United States of America, 2007
- Complement-targeted therapeuticsNature Biotechnology, 2007
- Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in miceJournal of Neuroinflammation, 2007
- Structural transitions of complement component C3 and its activation productsProceedings of the National Academy of Sciences of the United States of America, 2006
- Selective and efficient inhibition of the alternative pathway of complement by a mAb that recognizes C3b/iC3bMolecular Immunology, 2006
- High-affinity Human Antibodies from Phage-displayed Synthetic Fab Libraries with a Single Framework ScaffoldJournal of Molecular Biology, 2004
- C5 Convertase of the Alternative Pathway of ComplementPublished by Elsevier BV ,1998
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D-Biological Crystallography, 1997
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997
- Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor BBiochemistry, 1992